Evolus Inc (NASDAQ:EOLS)
| 3.76 Delayed Data As of 3:56pm ET |  +0.05 / +1.35%Today’s Change | 3.00 Today|||52-Week Range 19.00 | -69.10% Year-to-Date |
Latest EOLS News | Press Releases
No recent news for Evolus Inc.
Today’s Trading
| Previous close | 3.71 |
| Today’s open | 4.08 |
| Day’s range | 3.74 - 4.10 |
| Volume | 62,259 |
| Average volume (3 months) | 938,912 |
| Market cap | $115.7M |
Data as of 3:56pm ET, 08/11/2020
Growth & Valuation
| Earnings growth (last year) | -66.01% |
| Earnings growth (this year) | +6.27% |
| Earnings growth (next 5 years) | +33.50% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 9.84 |
| Price/Book | 1.45 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GNPXGenprex Inc | -0.21 | -5.54% |
| ACRXAcelRx Pharmaceutica... | -0.17 | -12.00% |
| MNKMallinckrodt PLC | -0.10 | -7.00% |
| LUMOLumos Pharma Inc | -0.29 | -1.93% |
Data as of 3:59pm ET, 08/11/2020
Financials
| Next reporting date | November 9, 2020 |
| EPS forecast (this quarter) | -$0.45 |
| Annual revenue (last year) | $34.9M |
| Annual profit (last year) | -$90.0M |
| Net profit margin | -257.79% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Newport Beach, California |
Forecasts
